4-Ethylbenzene-1,3-diol, 95.0%, 1g

4-Bromo-6-chloronicotinonitrile, 95+%, 1g

3-Nitrophenylacetylene, 95.0%, 5g

4-(1-(tert-Butoxycarbonyl)azetidin-3-yl)benzoic acid, 95.0%, 250mg

N-benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine, 95+%, 5g

2-Methoxy-4-methylbenzoic acid, 98.0%, 5g

Triphenylchlorosilane>95.0%(GC)5g

2-Bromothiazolo[5,4-b]pyridine, 95.0%, 10g

Di-tert-butyl 4-chloropyridine-2,6-dicarboxylate, 95%, 100mg

1,3,5-Tris[(1H-imidazol-1-yl)methyl]benzene>95.0%(HPLC)(T)1g

6-Amino-3-methylpyrimidin-4(3H)-one, 95.0%, 250mg

Gilteritinib, 95%, 250mg

Fmoc-PEG2-C2-NHS ester, 250mg